191 related articles for article (PubMed ID: 17309175)
21. [Endometrial cancer in HNPCC syndrome].
Lécuru F; Ansquer Y; Bats AS; Olschwang S; Laurent-Puig P; Eisinger F
J Gynecol Obstet Biol Reprod (Paris); 2008 Oct; 37(6):547-53. PubMed ID: 18650032
[TBL] [Abstract][Full Text] [Related]
22. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
Wheeler CM
Nat Clin Pract Oncol; 2007 Apr; 4(4):224-35. PubMed ID: 17392713
[TBL] [Abstract][Full Text] [Related]
23. Screening and chemoprevention of gynecologic tumors.
Schottenfeld D; Follen Mitchell M; Hong WK
Obstet Gynecol Clin North Am; 1996 Jun; 23(2):285-94. PubMed ID: 8784882
[TBL] [Abstract][Full Text] [Related]
24. [Breast cancer prevention: from chemoprevention to prophylactic surgery].
Morcel K; Rouquette S; Dugast C; Bendavid C; Audrain O; Levêque J
J Gynecol Obstet Biol Reprod (Paris); 2008 Nov; 37(7):661-71. PubMed ID: 18653291
[TBL] [Abstract][Full Text] [Related]
25. Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003.
Jensen KE; Hannibal CG; Nielsen A; Jensen A; Nøhr B; Munk C; Kjaer SK
Eur J Cancer; 2008 Sep; 44(14):2003-17. PubMed ID: 18662869
[TBL] [Abstract][Full Text] [Related]
26. [Chemoprevention and prophylactic surgery in ovarian carcinoma].
Deffieux X; Touboul C; Uzan C; Faivre E; Frydman R; Fernandez H; Morice P
J Gynecol Obstet Biol Reprod (Paris); 2007 Dec; 36(8):756-63. PubMed ID: 17719183
[TBL] [Abstract][Full Text] [Related]
27. [On methods for control and prevention of cancer of the female genitalia used at the Preventive Gynecology Department of the Antitubercular Provincial Association of Turin].
Concina E; Pavetto PF; Cristina MV; Campogrande M
Minerva Ginecol; 1974 Jun; 26(6):332-5. PubMed ID: 4846846
[No Abstract] [Full Text] [Related]
28. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario.
Jiménez W; Paszat L; Kupets R; Wilton A; Tinmouth J
Gynecol Oncol; 2009 Sep; 114(3):395-8. PubMed ID: 19501390
[TBL] [Abstract][Full Text] [Related]
29. [Late hematogenous infection of prosthetic joints in our patients and proposal for a system of prevention].
Jahoda D; Nyc O; Simsa J; Kucera E; Hanek P; Chrz P; Pokorný D; Tawa N; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2007 Dec; 74(6):397-400. PubMed ID: 18198090
[TBL] [Abstract][Full Text] [Related]
30. [Gynaecological cancer and development of surgical infections].
Ivanov S; Ivanov S
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():15-6. PubMed ID: 16028397
[TBL] [Abstract][Full Text] [Related]
31. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?
Gultekin M; Kucukyildiz I; Karaca MZ; Dundar S; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
Int J Gynecol Cancer; 2017 Oct; 27(8S Suppl 1):S1-S9. PubMed ID: 28937544
[TBL] [Abstract][Full Text] [Related]
32. Mass controlled examinations of women for detection of gynecological cancer in Medvescak-Zagreb.
Audy S; Bacic M; Bagovic P; Bolanca M; Urbanke A; Vodopija I
Minerva Ginecol; 1971 Jan; 23(1):20-2. PubMed ID: 5553176
[No Abstract] [Full Text] [Related]
33. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness.
Bray F; Parkin DM
Eur J Cancer; 2009 Mar; 45(5):747-55. PubMed ID: 19117750
[TBL] [Abstract][Full Text] [Related]
34. The use of cervical screening history data to interpret cervical cancer incidence trends.
Clare J; Edwards D; Bagnall H; Pearmain P; Lawrence G
J Public Health (Oxf); 2008 Jun; 30(2):171-7. PubMed ID: 18296455
[TBL] [Abstract][Full Text] [Related]
35. Oncoprevention in gynecology.
Dhakal S
JNMA J Nepal Med Assoc; 2010; 49(178):167-73. PubMed ID: 21485608
[TBL] [Abstract][Full Text] [Related]
36. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?
Gultekin M; Kucukyildiz I; Karaca MZ; Dundar S; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
Int J Gynecol Cancer; 2017 Sep; 27(7):1525-1533. PubMed ID: 28708790
[TBL] [Abstract][Full Text] [Related]
37. [Screening for prevention of cervical cancer in the Czech Republic].
Tachezy R; Rob L
Cas Lek Cesk; 2007; 146(12):939-44. PubMed ID: 18257411
[TBL] [Abstract][Full Text] [Related]
38. Low cost methods for secondary prevention of cervical cancer in developing countries.
Anorlu RI; Ola ER; Abudu OO
Niger Postgrad Med J; 2007 Sep; 14(3):242-6. PubMed ID: 17767211
[TBL] [Abstract][Full Text] [Related]
39. Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals.
Funston G; O'Flynn H; Ryan NAJ; Hamilton W; Crosbie EJ
Adv Ther; 2018 Apr; 35(4):577-589. PubMed ID: 29516408
[TBL] [Abstract][Full Text] [Related]
40. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
